CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 52 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2019. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,217,075 | +85.1% | 371,260 | +128.2% | 0.00% | +100.0% |
Q2 2023 | $5,519,868 | -61.0% | 162,684 | -58.7% | 0.00% | -66.7% |
Q1 2023 | $14,169,140 | -2.9% | 393,806 | +20.3% | 0.00% | -25.0% |
Q4 2022 | $14,594,892 | +32.9% | 327,460 | -16.2% | 0.00% | +33.3% |
Q3 2022 | $10,979,000 | -35.4% | 390,551 | -38.0% | 0.00% | -25.0% |
Q2 2022 | $16,989,000 | +6.4% | 630,165 | +34.4% | 0.00% | +33.3% |
Q1 2022 | $15,968,000 | -68.6% | 468,802 | -64.4% | 0.00% | +200.0% |
Q4 2021 | $50,842,000 | +33.3% | 1,315,778 | +86.2% | 0.00% | -80.0% |
Q3 2021 | $38,147,000 | +105.3% | 706,560 | +27.1% | 0.01% | +66.7% |
Q2 2021 | $18,585,000 | -8.0% | 555,748 | -43.3% | 0.00% | 0.0% |
Q1 2021 | $20,209,000 | +18.6% | 981,009 | +0.9% | 0.00% | +200.0% |
Q4 2020 | $17,036,000 | +274.5% | 972,274 | +217.0% | 0.00% | 0.0% |
Q3 2020 | $4,549,000 | -25.7% | 306,700 | -34.9% | 0.00% | 0.0% |
Q2 2020 | $6,125,000 | +6214.4% | 471,163 | +705.9% | 0.00% | – |
Q1 2020 | $97,000 | -40.1% | 58,461 | -19.2% | 0.00% | – |
Q4 2019 | $162,000 | -6.4% | 72,309 | -11.0% | 0.00% | – |
Q3 2019 | $173,000 | -61.6% | 81,253 | -51.5% | 0.00% | – |
Q2 2019 | $450,000 | +78.6% | 167,700 | +227.0% | 0.00% | – |
Q1 2019 | $252,000 | – | 51,282 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 2,600,000 | $88,218,000 | 12.13% |
Octagon Capital Advisors LP | 759,898 | $25,783,339 | 3.59% |
TSP Capital Management Group, LLC | 251,895 | $8,546,800 | 3.08% |
ACUTA CAPITAL PARTNERS, LLC | 122,343 | $4,151,098 | 2.81% |
5AM Venture Management, LLC | 310,270 | $10,527,461 | 2.62% |
COMMODORE CAPITAL LP | 631,665 | $21,432,393 | 2.41% |
RTW INVESTMENTS, LP | 3,463,201 | $117,506,410 | 2.24% |
Eversept Partners, LP | 785,740 | $26,660,158 | 2.23% |
Redmile Group, LLC | 1,696,004 | $57,545,416 | 2.21% |
Affinity Asset Advisors, LLC | 87,031 | $2,952,962 | 1.03% |